CPC
BSX icon

Congress Park Capital’s Boston Scientific BSX Stock Holding History

Congress Park Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+5,250
New +$285K 0.06% 124

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Congress Park Capital's BSX Position: Q2 2026 in Review

Congress Park Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 5,250 shares worth $224K. The stake represents 0.06% of the portfolio and ranks #124 among its holdings.

534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Congress Park Capital held 5,250 shares of Boston Scientific worth $224K as of Q2 2026.
  • Boston Scientific was a new Congress Park Capital position in Q2 2026.
  • Boston Scientific made up 0.06% of Congress Park Capital's portfolio in Q2 2026, its #124 holding.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Congress Park Capital's 13F filing for Q2 2026, filed 14 Jul 2026.